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Vitamin A plays an essential role in the maintenance of gut homeostasis but its interplay with chemokines has not been explored
so far. Using an in vitromodel system we studied the effects of human colonic epithelial cells (Caco2, HT-29, and HCT116) derived
inflammatory stimuli onmonocyte-derived dendritic cells andmacrophages. Unstimulated Caco2 andHT-29 cells secreted CCL19,
CCL21, and CCL22 chemokines, which could attract dendritic cells and macrophages and induced CCR7 receptor up-regulation
by retinoic-acid resulting in dendritic cell migration.The chemokines Mk, CXCL16, and CXCL7were secreted by all the 3 cell lines
tested, and upon stimulation by IL-1훽 or TNF-훼 this effect was inhibited byATRAbut had no impact onCXCL1, CXCL8, andCCL20
secretion in response to IL-1훽. In the presence of ATRA the supernatants of these cells induced CD103 expression on monocyte-
derived dendritic cells and when conditioned by ATRA and cocultured with CD4+ T-lymphocytes they reduced the proportion
ofTh17 T-cells. However, in the macrophage-T-cell cocultures the number of these effector T-cells was increased.Thus cytokine-
activated colonic epithelial cells trigger the secretion of distinct combinations of chemokines depending on the proinflammatory
stimulus and are controlled by retinoic acid, which also governs dendritic cell and macrophage responses.
1. Introduction
The adult human intestine is referred to as “physiologically
inflamed” due to the presence of enormous number of B-
and T-lymphocytes, as well as macrophages (Mf), dendritic
cells (DC), eosinophils, and mast cells. If all these immune
cells were present in other tissues at such concentrations, they
would be regarded as an abnormal chronic inflammatory cell
infiltrate [1]. In such a scenario, the main players maintaining
gut homeostasis should be those mechanisms that provide
tolerogenic signals for specialized myeloid cells with antigen
presenting function.
The vitamin A (VitA) metabolite retinoic acid (RA) is a
key regulator of the cytokine TGF-훽, which promotes Treg
differentiation [2]. VitA also contributes to the formation of
epithelial linings of mucosal surfaces [3], and its multifunc-
tionalmetabolite RA [4] acts as a critical driver of lymphocyte
trafficking to the intestinal mucosa [5]. All-trans retinoic acid
(ATRA) induces the expression of the gut homing integrin훼4훽7 on myeloid cells and the chemokine receptor CCR9
on T-lymphocytes, while the lack of the 훼v or 훽8 integrin
chains in DC impairs Treg functions and Th17 responses in
vivo [6]. ATRA also modulates Th17 effector T-lymphocyte
differentiation in the gut [7]; however, the in vivo effects
of ATRA in intestinal and extraintestinal compartments
result in controversial outcomes presumably due to targeting
multiple cell types with diverse functional activities [8]. VitA
deficiency has an effect on epithelial cell integrity and the
composition of the gut microbiota [9].
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A single layer of colonic epithelial cells (CEC) forms the
first line of defense against luminal pathogens. It commu-
nicates with other immune cells by direct contacts and by
secreting an array of cytokines and chemokines. Chemokines
represent low-molecular-weight proteins with pleiotropic
effects on the recruitment and activation of leukocytes at
inflammatory sites [10]. The dominant cell populations in
the gut involve CX3CR1+ Mf, which directly sense luminal
content by their extended membrane protrusions across the
epithelium [11], and migratory CD103+ DC with tolerogenic
potential. Apart from chemokines, colony-stimulating factor
(CSF-2/GM-CSF) in the gut is a multifunctional cytokine
that has an impact on DC and Mf numbers and can impair
the ability of immune cells to produce regulatory factors
such as RA and IL-10 and thus may lead to disrupted Treg
homeostasis in the large intestine [12]. It also acts as an
important regulator of humanDC homeostasis by promoting
in vivo expansion and differentiation from hematopoietic
progenitors and monocytes [13]. Under steady state con-
ditions, the low number of gut migratory DC is critically
dependent on GM-CSF, but its level is dramatically increased
during infection or inflammation and supports the develop-
ment of DC precursors such as monocytes and inflammatory
migratory DC thus modulating the composition of the DC
pool [14].
Cytokines have been shown to be the causative factor and
outcome of IBD pathogenesis. The major conclusive result
has been shown by improvement in the IBD symptoms by
blocking TNF-훼. And a decrease in the IL-1 receptor antag-
onist in comparison to IL-1 was observed in IBD patients
[15].These data confirm that both TNF-훼 and IL-1훽 are able
to trigger inflammatory conditions such as those observed
in Crohn’s disease (CD) or ulcerative colitis (UC) but the
comparison of their effects at molecular and functional levels
in context of the human intestinal microenvironment has not
been elucidated so far. Despite similarities in the functional
and regulatory mechanisms in human and mouse, major
differences have been observed in their cytokine secretion
[16] and mucus layer organization [17].
Based on these data and to overcome the discrepancies
between the human and mouse systems, we designed exper-
iments with human CEC in resting state and in an inflam-
matory milieu mimicked with TNF-훼 or IL-1훽 stimulation
in the presence or absence of ATRA.This was performed by
monitoring the levels of secreted chemokinesmeasured at the
protein level and by investigating their impact on the phe-
notype and functional attributes of myeloid cells generated
by different growth/differentiation factors. Considering that
DC have the potential to instruct T-cells for inflammatory
or regulatory directions, our final goal was to identify the
impact of stimulated CEC-induced and DC-mediated effects
on CD4+ effector T-lymphocyte responses. We could detect
the secretion of CCL19, CCL21, and CCL22 chemokines by
unstimulatedCEC,which has not been shownbefore.We also
observed that both IL-1훽 and TNF-훼 were able to trigger the
secretion of Midkine (Mk), CXCL16, and CXCL7 by CEC,
but their expression could efficiently be downregulated by
ATRA. However, the secretion of CXCL1, CXCL8, or CCL20
by IL-1훽-stimulated CEC was not influenced by ATRA. Our
results also revealed that the in vitro induced inflammatory
milieu created by proinflammatory chemokineswas sufficient
to increase the migratory potential of DC driven by GM-
CSF but not by the other growth factors, and ATRA could
further potentiate this effect. Furthermore, the molecular
information collected by CEC and transmitted to DC could
be translated to T-lymphocytes, which responded to CEC-
initiated and DC-mediated stimulation by mounting Th17
responses. All these steps seemed to be under the control of
ATRA as the response of CEC to both IL-1훽 and TNF-훼 was
higher in the presence of ATRA.
2. Materials and Methods
2.1. Cell Culture of Caco2 Colon Epithelial Cells. The human
colorectal adenocarcinoma cell line Caco2 is from ATCC-
number HTB-37 and HT-29 is from ATCC-number HTB-
38.The colorectal carcinoma cell line HCT116was a generous
gift from Dr. Gyo¨rgy Vereb, Department of Biophysics, Uni-
versity of Debrecen. Caco2 and HCT116 cells were cultured
in RPMI-1640 medium supplemented with 1% antibiotic-
antimycotic solution and 20% fetal bovine serum (GIBCO
by Life Technologies, EU) in tissue culture flasks (Nunclon,
Rochester, NY) at 37∘C in 10% and 5%CO2, respectively. HT-
29 cells were cultured in RPMI-1640 medium supplemented
with 1% antibiotic-antimycotic solution and 10% fetal bovine
serum in 5% CO2. Cell culture medium was replaced every
2-3 days and the cells were passaged when subconfluent.
2.2. Protein Array for Chemokine Analyses. CEC of 70–80%
confluency were plated overnight in RPMI supplemented
with 10% FCS-followed by stimulation with 10 ng/mL proin-
flammatory cytokines (IL-1훽 or TNF-훼) in combination with
orwithout 10 nmolATRAor leftuntreated for 1hour.The cells
were washed and replaced with fresh medium for 5 hr, when
the supernatants were collected for chemokine analysis per-
formed by a commercially available protein array (Proteome
Profiler Arrays—ARY017, R&D Systems, Minneapolis, MN,
USA) according to the manufacturer’s instructions. Sample
controls (transferrin R, gp130, and fibrinogen) included in
the array allowed us the detection and quantitation of the
secreted chemokines. Considering that ATRA dissolved in
DMSO may have toxic effects on resting CEC, which could
be further enhanced by activation with IL-1훽 or TNF-훼, we
performed preliminary titration experiments to optimize the
cell culture conditions by using 24 h 7AAD-based viability
assays performed by FACS analysis. These results indicated
98% viability of Caco2 and HT-29 cells in both the presence
and absence of 10 nmol ATRA that was similar to those
measured for untreated CEC.
2.3. In Vitro Cell Migration and the Chemotaxis Assay.
Migration of three different groups of monocyte-derived
cells, differentiated in GM-CSF+IL-4, GM-CSF, and M-CSF,
was tested for cell migration to chemokines and cytokines
secreted by Caco2, HT-29, and HCT116 cells. Monocytes(3 × 105) differentiated in the presence of the 3 different
growth factors were placed on the upper chamber of a 5-
micron Corning transwell plate and the CEC supernatants
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were added to the lower chamber of the transwell. After
24 h the monocyte-derived cells that migrated to the lower
chamberwere collected. 10,000polystyrene beads (15micron)
were added to each sample (Fluka Analytical, Germany) and
the number of migrating cells was counted by FACS Calibur
(BD Biosciences, Franklin Lakes, NJ, USA). The data were
analyzed by the FlowJo software (Tree Star, Ashland, OR,
USA).
2.4. Peripheral Blood Monocyte-Derived Cells. Leukocyte
enriched buffy coats were obtained from healthy blood
donors drawn at the Regional Blood Center of the Hungarian
National Blood Transfusion Service (Debrecen, Hungary)
in accordance with the written approval of the Director of
the National Blood Transfusion Service and the Regional
and Institutional Ethics Committee of the University of
Debrecen, Medical and Health Science Center (Hungary).
PBMCs were separated by a standard density gradient cen-
trifugation with Ficoll-Paque Plus (Amersham Biosciences,
Uppsala, Sweden). Monocytes were purified from PBMCs
by positive selection using immunomagnetic cell separation
with anti-CD14microbeads, according to the manufacturer’s
instruction (Miltenyi Biotec, Bergisch Gladbach, Germany).
After separation on a VarioMACS magnet, 96–99% of the
cells were CD14+ monocytes, as measured by flow cytometry.
Monocyteswere divided and cultured in 12-well tissue culture
plates at a density of 2 × 106 cells/mL in 10% RPMI medium
supplemented with four different growth factors: 80 ng/ml
GM-CSF (Gentaur Molecular Products, Brussels, Belgium),
100 ng/mL IL-4 (PeproTech EC, London, UK), and M-CSF
50 ng/mL (MACS, Miltenyi Biotec, Germany).
2.5. Peripheral Blood Lymphocytes and CD4+ T-Cells. Autol-
ogous naive T-cells were separated from human blood
mononuclear cells using the naive CD4+ T-cell isolation kit
based on negative selection according to the manufacturer’s
instruction (Miltenyi Biotec).
2.6. Phenotypic Characterization of Myeloid Cells by Flow
Cytometry. Detection of the cell surface expression of
monocyte-derived myeloid cells was performed by flow
cytometry using anti-CD1a-PE, anti-CD209-PE, anti-CD14-
PE, anti-CD83-PE, anti-CD103-PE, anti-CX3CR1-PE, and
anti-CCR7-PE (Beckman Coulter, Hialeah, FL, USA). The
growth factor receptors were characterized by anti-GM-
CSFR훼-PE and anti-M-CSF R/CD115-PE (R&D Systems,
USA) and isotype-matched control antibodies (BD PharMin-
gen, San Diego, CA, USA). Fluorescence intensities were
measured by FACS Calibur (BD Biosciences, Franklin Lakes,
NJ, USA), and data were analyzed by the FlowJo software
(Tree Star, Ashland, OR, USA).The human chemokines Mk,
CXCL7, CCL20, and CXCL16 were ordered from PeproTech,
UK; CXCL8 and CXCL1 are fromMiltenyi Biotec.
2.7. IL-17 and IFN훾 ELISPOT Assays. The monocyte-derived
cells were cultured in GM-CSF+IL-4, GM-CSF, and M-CSF
for 3 days along with the supernatant of unstimulated or
cytokine activated Caco2 cells at 2 × 105 cells/well density.
The cells were washed to remove all growth factors and
supernatants and were cocultured with na¨ıve autologous
CD4+ T cells (106cells/well) in 10% RPMI medium for 2
days at 37∘C in a humidified atmosphere containing 5%
CO2. PHA and Con A activated T cells were used as pos-
itive controls. Negative controls involved CD4+ T-cells and
untreated monocyte-derived cells cocultured with CD4+ T-
cell. Detection of cytokine-secreting T cells was performed by
the avidin-HRP system (NatuTec GmbH, Germany). Plates
were analyzed by an ImmunoScan plate reader (CTL, Shaker
Heights, OH, USA).
2.8. Statistical Analysis. Statistical analysis was performed
by one-way analysis of variance (ANOVA) for multiple
comparisons. Results are expressed as mean ± SD. Two group
differences were analyzed by Student’s t-test. P value (two-
tailed) less than 0.05 was considered statistically significant.
3. Results
3.1. Identification of Chemokines Secreted by Resting and
Activated CEC. The single cell monolayer of CEC plays an
essential role in the maintenance of gut homeostasis by
supporting barrier function and defense against microbes
preferentially through the secretion of chemokines [18]. It
is also well established that the proinflammatory cytokines
IL-1훽 and TNF-훼 act as potent activators of CEC [19].
In this study we applied a high throughput approach for
identifying the chemokines secreted by CEC (Caco2, HT-29,
and HCT116) in response to IL-1훽 and TNF-훼 by using a
commercially availableHumanChemokineArray to quantify
the relative levels of chemokines released by resting and
activated CEC at the protein level. The sample controls
provided (transferrin R, gp130, and fibrinogen) were used for
calculating mean pixel densities of the respective dot blots.
The results showed that resting Caco2 cells secrete detectable
levels of CCL19, CCL21, and CCL22 constitutively (dots 2D,
9F, and 8D in Figure 1(a), summarized in Figure 1(c)). Similar
results were obtained for HT-29 cells, but HCT116 secreted
only CCL19 at detectable levels. Comparison of the relative
cytokine levels secreted by the Caco2, HT-29, and HCT116
cell lines are summarized in Table 1. Considering that these
CCL chemokines are known to attractmyeloid cells, theymay
maintain a population of myeloid cells in the vicinity of CEC
to support cellular interactions. It has previously been shown
that MDC/CCL22 attractsTh2 cytokine producing cells and
its mRNA and protein expression is upregulated against
enteroinvasive bacteria, but inhibition of the NF-휅B pathway
abolished CCL22 expression in response to proinflammatory
stimuli [1]. The chemokines CXCL7, CXCL16, and Mk with
different functional activities were also constitutively secreted
by resting CEC (dot 9C, 7F, and 7D in Figure 1(a)) suggesting
their role in the maintenance of epithelial cell homeostasis.
3.2. The Effect of ATRA on the Chemokine Secretion by CEC
Prestimulated by IL-1훽 or TNF-훼. In our model system,
CEC were left untreated or stimulated by IL-1훽 or TNF-훼 in combination with or without ATRA for 6 hr and the
cell culture supernatants were subjected to chemokine array
analysis by calculating pixel densities using the relevant
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Figure 1: Chemokine secretion of human epithelial cells activated by IL-1훽 or TNF-훼 in the presence or absence of ATRA. Caco2 cells were
activated by 10 ng/mL IL-1훽 or TNF-훼 in the presence or absence of 10 nmol ATRA. After 1 hr of activation, the supernatants were removed
and the cells werewashed and cultured in freshmedium.After 5 hr the supernatants of nontreated and activatedCaco2 cells were collected and
the relative levels of chemokines were determined by a Proteome Profiler Array used according to themanufacturer’s instructions.The relative
levels of the Caco2 cell-derived chemokines were determined by calculating mean pixel densities of the individual blots normalized to sample
control fibrinogen. The mean ± SD of 4 independent measurements is shown. (a) Localization of the chemokine probes in the membranes
related to the positive controls and the reference spots. (b) Representative dot blots showing the relative expression of chemokines produced
by untreated Caco2 cells without or with ATRA (upper and lower panels 1) as compared to Caco2 cells stimulated by IL-1훽 (upper panel 2)
and IL-1훽 in the presence of ATRA (lower panel 2). Upper and lower panels 3 correspond to Caco2 cells stimulated by TNF-훼 in the absence
or presence of ATRA, respectively. (c) Relative expression levels of CCL chemokines produced by unstimulated Caco2 cells.
sample control (Figure 1). When Caco2 cells were activated
by TNF-훼 or IL-1훽, the secretion levels of the chemokines
CXCL7, CXCL16, and Mk did not change significantly as
compared to unstimulated cells (dots 9C, 7F, and 7D in
Figure 1(a), summarized in Figures 2(a) and 2(b)). However,
the expression of CXCL16 and Mk was downregulated in
the presence of ATRA suggesting that the secretion of these
chemokines may contribute to the maintenance of epithelial
cell homeostasis. However, under inflammatory conditions
they do not mediate positive signals for DC. Remarkably, the
secretion of CXCL7 (dot 9C in Figure 1(a), summarized in
Figures 2(a) and 2(b)) could be induced only when IL-1훽 or
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Table 1: Relative expression of chemokines secreted by colon epithelial cell lines. Caco2, HT-29, and HCT116 cells were treated with IL-1훽 or
TNF-훼 in the presence or absence of ATRA for 60min. After removing the cell culture supernatant the cells were washed and replaced with
fresh medium and the supernatants were collected after 5 hours and used for the Chemokine Array analysis according to the manufacturer’s
instruction to determine the variety of chemokines secreted by these cell lines.The values indicate the results of the densitometric analysis of
dot blots and are normalized to the relevant sample control according to themanufacturer’s instructions. For simplicity the value of 1 obtained
after dividing with the sample control is referred to as 100.
CCL19 CCL21 CCL22 Mk CXCL16 CXCL7 CXCL1 CXCL8 CCL20
C
Caco2 30 30 30 90 70 40 — — —
HT-29 40 30 40 80 90 60 — — —
HCT-116 150 — — 170 170 — — 120 —
IL-1훽 Caco2 — — — 100 80 — 120 140 30HT-29 — — — 80 90 — 100 90 30
HCT-116 — — — 150 160 100 100 100 100
IL-1훽 + ATRA Caco2 — — — 110 80 50 100 130 —HT-29 — — — 100 80 40 100 90 —
HCT-116 — — — 160 140 90 110 110 —
TNF-훼 Caco2 — — — 90 60 — — — —HT-29 — — — 80 60 — — — —
HCT-116 — — — 150 150 — 10 10 —
TNF-훼 + ATRA Caco2 — — — 90 60 — — — —HT-29 — — — 90 80 20 — — —
HCT-116 — — — 150 130 20 10 — —
ATRA
Caco2 — — — 50 30 — — — —
HT-29 — — — 60 20 — — — —
HCT-116 40 20 30 80 80 — — — —
TNF-훼 was combined with ATRA treatment demonstrating
the dependence of its secretion on ATRA. DMSO, which
is the standard solvent of ATRA, also decreased CXCL7
secretion (Figures 2(a) and 2(b)). Depending on CEC sensi-
tivity to DMSO, certain effects of this solvent have previously
been reported, as inhibition of prostaglandin E2 production
upon treatment of Caco2 cells with IL-1훽 and attenuation of
mRNA levels of IL6, IL-1훼, and IL-1훽 [20]. These findings
might be in line with inhibition of CXCL7 observed in
our system. In the IEC-18 cell line IL-1훽 induced increased
mRNA levels of MCP-1/CCL2, MIP-1훼/CCL3, inducible NO
synthase, and RANTES/CCL5, which are upregulated in a
NF-휅B dependent manner [21].
The secretion levels of CCL20 and CXCL1 were not
affected by ATRA (dots 3D, 2F, and 7E in Figure 1(a),
summarized in Figure 2(c)) and could be induced exclusively
by IL-1훽 but not by TNF-훼. Surprisingly, CXCL8 secretion
was upregulated not only by IL-훽 with or without ATRA,
but also by DMSO used as a vehicle for ATRA (Figure 2(c)).
DMSO induced strain on the actin cytoskeleton and integrins
expressed by Caco2 cells was suggested to be transferred
to actin-associated molecules like 훼-actinin-1, acting as a
scaffold protein and interacted directly with ERK1/2 leading
to phosphorylation and increased secretion of CXCL8. The
in vivo relevance of this effect is underscored by the physical
deformation of CEC during peristalsis and villous motility
[22]. Along with IL-8/CXCL8 andGRO훼/CXCL1, Caco2 cells
also express MCP-1/CCL2 as a result of IL-1 stimulation, but
our chemokine array-based method did not detect CCL2
[23]. These results suggest that the expression of individual
chemokines depends on the means of activation and also
on ATRA, which can modulate the outcome of chemokine
secretion, whereas the group of chemokines not affected
by ATRA indicates the complexity of chemokine-mediated
regulation in the gut. Similar results were obtained for HT-
29 and HCT116 CEC as summarized in Table 1. Even though
HCT116 showed a similar overall pattern of chemokine secre-
tion as the other CEC, trace amounts of NF-휅B-dependent
inflammatory chemokines (CCL2, CXCL2, andCXCL10), not
observed in Caco2 and HT29 cells, were detected indicating
CEC type-dependent regulation of chemokine secretion [10,
21, 24].
3.3. ATRA Regulates the Chemokine-Dependent Migration
of Myeloid Cells Generated by Different Hematopoietic
Growth/Differentiation Factors. Based on the results showing
the inhibitory effect of ATRA on the secretion of some
chemokines, we next sought to assess the chemokine-driven
migratory potential of myeloid cells. We set up a transwell
system and measured myeloid cell migration in vitro by
using CCL19 and CCL21 chemokines as positive controls of
cell recruitment. Myeloid cells differentiated from primary
human monocytes by GM-CSF+IL-4 or GM-CSF to DC
exhibited detectable but lowmigratory potential as compared
to cells mobilized by high concentration (200 ng/mL) of
CCL19 and CCL21 chemokines (Figures 3(a) and 3(b)), while
monocytes cultured inM-CSF gave rise to macrophages with
undetectablemigratory activity (data not shown).The highest
migratory potential could be attributed to cells differentiated
in the presence of GM-CSF or GM-CSF+IL-4 and stimulated
by the supernatant of Caco2 cells preactivated by IL-1훽, but
this process could be downregulated by ATRA. To analyze
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Figure 2: Effects of ATRA on the expression of chemokines in cytokine-stimulated Caco2 cells. Relative expression of chemokines in Caco2
cells, prestimulated by TNF-훼 or IL-1훽 in the presence or absence of ATRA, was determined as described in Figure 1 and was compared to
unstimulated cells cultured with or without ATRA.The possible contribution of DMSOused as a solvent control of ATRAwas tested in Caco2
cells cultured in the presence of TNF-훼 or IL-1훽 with or without DMSO. (a) Expression of chemokines secreted by Caco2 cells prestimulated
by TNF-훼, in the presence or absence of ATRA. (b) Expression of chemokines secreted by Caco2 cells prestimulated by IL-1훽 in the presence
or absence of ATRA. (c) Chemokines induced exclusively by IL-1훽 stimulation in Caco2 cells. ∗푃 < 0.05 , ∗∗푃 < 0.01. Bar diagrams indicate
mean ± SD of 4 dot blots which was averaged after densitometry analysis and normalized with the “sample control” provided with the kit.
whether the supernatant of IL-1훽-stimulatedCEChas a direct
effect on the migration of DC differentiated by GM-CSF+IL-
4 or GM-CSF, the cells were subjected to direct cell migration
assays toward the chemokines exclusively secreted by IL-1훽
used at pretitrated concentrations (CXCL1 (1 ng/mL), CXCL8
(100 ng/mL), and CCL20 (50 ng/mL)). We observed the high
migratory capacity of DC differentiated by GM-CSF+IL-4
(Figure 3(c)) and Mf developed by GM-CSF (Figure 3(d))
toward CXCL1 and CXCL8 known to be involved in the
chemotaxis and migration of polymorphonuclear leukocytes
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Figure 3: ATRAmodifies the chemokine-dependent migration of in vitro differentiatedmyeloid cells. Caco2 cells were activated as described
in Figure 1.The migratory potential of the monocyte-derived cells generated by GM-CSF+IL-4 or GM-CSF was tested in transwell chambers.3 × 105 cells were placed on the upper chamber and the Caco2 cell supernatants on the lower chamber of the transwell plate. After 24 hr,
the number of cells, which migrated to the lower chamber in response to the Caco2 cell supernatants, was counted by flow cytometry. The
migratory potential of cells generated in the presence of GM-CSF+IL-4 (a) or GM-CSF (b) is shown as compared to the migratory potential
of CCL19 and CCL21 chemokines, used as positive controls. To determine the cause of high migration in response to IL-1훽 treated CEC
supernatant, the GM-CSF+IL-4 (c) and GM-CSF (d) differentiated monocytes were treated with CXCL1, CXCL8, and CCL20 chemokines
whichwere secreted exclusively by CECon IL-1훽 treatment. Bar diagrams indicatemean± SD of 3 independent experiments ∗푃 < 0.05, ∗∗푃 <0.01, and ∗∗∗푃 < 0.001. Another fraction of monocyte-derived cells, differentiated by GM-CSF+IL-4 or GM-CSF, was also stimulated by the
supernatant of IL-1훽 pretreated CEC in the presence or absence of ATRA.The cell surface expression of CCR7 in the differentiated monocyte
derived cells was measured by flow cytometry (e). Red line depicts untreated monocyte-derived cells, green is for monocyte-derived cells
treated by the supernatant of Caco2 cells previously activated by IL-1훽, blue line is for monocyte-derived cells pretreated with the supernatant
of Caco2 cells activated by IL-1훽 and ATRA, and brown line corresponds to cells treated by the supernatant of unstimulated Caco2 cells in
combination with ATRA. Results of 3 independent experiments are shown as mean ± SD of MFI.
to inflammatory sites [25, 26] as compared to CCL20.
Interestingly, the supernatant of Caco2 cells prestimulated
with TNF-훼 had no such effect on cell migration (Figures
3(a) and 3(b)). When the migratory potential of myeloid cells
was related to the cell surface expression of CCR7 we found
that DC differentiated by GM-CSF in the presence of ATRA-
conditioned CEC supernatant exhibited decreased CCR7
expression, while in cells differentiated in GM-CSF+IL-4
it remained unchanged (Figure 3(e)). Similar results were
obtained by using the HT-29 and HCT116 cell lines (data
not shown). These results suggest that in an inflammatory
environment ATRA also modulates the migratory potential
of myeloid cells in a cell type-dependent manner.
3.4. ATRA Supports the Development of Migratory CD103+
MyeloidCells . The dominantDCpopulation of the gut is rep-
resented by CD103+ migratory cells that express the enzymes
required for the metabolism of VitA [4], while the CX3CR1+
resident Mf population samples the microenvironment by
protruding dendrites [11]. To assess how efficiently we could
manipulate the effects of ATRA on CEC, we differentiated
blood-derived monocytes with GM-CSF+IL-4 or M-CSF to
generateDC andMf, respectively, followed by the stimulation
of cells with the supernatant of activated Caco2 cells. The
cell surface expression of CD103+ and CX3CR1+ measured
by FACS analysis revealed that the presence of Caco2 cell
supernatants obtained fromATRA+IL-1훽, ATRA+TNF-훼, or
8 Mediators of Inflammation
ATRA-pretreated CEC could increase the expression of the
CD103 integrin in cells differentiated by GM-CSF+IL-4 or
M-CSF to obtain DC and Mf, respectively (Figures 4(a) and
4(b)). These results also indicated that even in the presence
of inflammatory stimuli (supernatant of IL-1훽 or TNF-훼
activated CEC) ATRA was able to promote the development
of CD103+ myeloid cells. In a similar experimental system,
the frequency of CX3CR1+ cells generated by GM-CSF+IL-4
and stimulated by cytokine-activated CEC supernatant was
also increased in case the cell culture was conditioned by
ATRA. In contrast to this finding, the expression of CX3CR1
remained unchanged in cells generated by GM-CSF (data not
shown) andwas decreasedwhen theATRA-conditionedCEC
supernatant was added to Mf differentiated from monocytes
with M-CSF and activated by IL-1훽 or TNF-훼 (Figures 4(c)
and 4(d)). Similar results were obtained with HT-29 and
HCT116 cells (data not shown). To confirm that the level
of ATRA could be reconstituted in CEC after the washing
procedure, we also added ATRA directly to DC and detected
increased expression of CD103. To rule out the effect of
other chemokines in the development of CD103+cells, the
chemokines secreted by activated CEC were added directly
to monocytes at pretitrated concentrations (Mk 10 ng/mL,
CXCL16 100 ng/mL, CXCL7 10 ng/mL, CXCL1 1 ng/mL,
CXCL8 100 ng/mL, and CCL20 50 ng/mL) along with the
differentiating growth factors GM-CSF+IL-4 or M-CSF and
the expression of CD103 was measured by FACS. When the
in vitro generated myeloid cells were treated directly with the
different chemokines in the absence of ATRA, no phenotypic
changes of DC and Mf could be detected (see Supplemen-
tary Figure 4 in Supplementary Material available online at
http://dx.doi.org/10.1155/2015/579830), showing their direct
dependence on ATRA.
3.5. Translation of the Molecular Information Collected by
CEC-StimulatedMyeloid Cells to CD4+ T-Lymphocytes. Con-
sidering the sensitivity of myeloid cells to proinflammatory
signals provided by activated CEC and themodulatory effects
of ATRA, we set out to test whether DC and Mf as antigen
presenting cells could activate and polarize T-lymphocytes.
To test this scenario, myeloid cells differentiated by GM-
CSF+IL-4, GM-CSF, and M-CSF, respectively, were activated
by supernatants of cytokine-activated Caco2 cells followed
by coculturing them with autologous CD4+ T-lymphocytes,
and the number of IL-17 and IFN훾 cytokine producing T-
cells was detected by ELISPOT assays.We found that CD4+ T
cells cocultured withmyeloid cells differentiated frommono-
cytes to DC with GM-CSF+IL-4 (Figure 5(a)) or GM-CSF
(Figure 5(b)) and “educated” by the supernatants of activated
Caco2 cells in combination with ATRA resulted in significant
suppression of IL-17 producing cell numbers. In contrast,
monocyte-derived cells generated by M-CSF pretreated with
Caco2 cell supernatant (Figure 5(c)) and subsequently co-
cultured with CD4+ T-cells, the number of IL-17 cytokine
secreting cells was increased significantly indicating that DC
andMf exhibit different T-cell polarizing activities. Although
slight differences could be observed in the magnitude of T-
cell responses provoked by CEC supernatants activated by
IL-1훽 or TNF-훼, the T-lymphocyte responses were polarized
to the Th17 direction in both cases independent of the
proinflammatory cytokine used for CEC stimulation under-
pinning the role of DC-mediated inflammatory signals in
drivingCD4+ T-lymphocyte responses.Under similar culture
conditions IFN훾-secreting cells could not be detected in the
CD4+ T-cell population. Similar “education” of myeloid cells
by ATRA-conditioning was observed also for HT-29 and
HCT116 cell lines (data not shown). Thus, ATRA is able
to exert different effects on monocyte-derived myeloid cells
differentiated upon coculturing with CD4+ T cells.This may
indicate a broad range of RA-mediated effects involved in
shaping the gut microenvironment.
4. Discussion
The cytokines secreted at increased levels in patients with
IBD have been identified as TNF-훼 and IL-1훽, but the
complete spectrum of chemokines and chemokine receptors
involved in these regulatory networks has not been analyzed
in detail. We designed an in vitro experimental system to
study the effects and the interplay of cytokines, chemokines,
and RA in resting CEC and under inflammatory conditions
for identifying the possible outcomes of myeloid cell-induced
T-cell collaboration (Supplementary Figure 1). We observed
that unstimulated CEC secrete CCL chemokines with the
potential to attract DC and Mf thus ensuring continuous
contact with CEC to support LP homeostasis [27, 28]. It
has previously been observed that TNF-훼 and IL-1훽 do not
induce the secretion of CCL22 in monocytes, macrophages,
and B cells from human peripheral blood in vitro, but
prolonged (12 hr) treatment could induce production of
MDC/CCL22 protein by cultured human intestinal epithelial
cells [1]. The detailed analysis of chemokine expression
induced by the supernatants of CEC preactivated by IL-
1훽 or TNF-훼 demonstrated that (1) the secretion of the
CCL20, CXCL1, and CXCL8 chemokines could be induced
only by IL-1훽 and was not affected by ATRA, (2) constitutive
expression of the chemokines Mk, CXCL16, and CXCL7 was
not modified by the supernatant of activated CEC, (3) ATRA
downregulated the expression of Mk and CXCL16, and (4)
the secretion of CXCL7 could be induced by both IL-1훽 and
TNF-훼 in the presence of ATRA. Consistent with previous
results, we also observed in our in vitro model that CXCL8
and CXCL1 are secreted upon activation of CEC by IL-1훽
but not by TNF-훼 showing that IL-1 family cytokines may
exert dichotomous or opposing effects in maintaining gut
homeostasis or inducing intestinal inflammation [29]. When
Caco2 cells were treated with TNF-훼 in combination with
Clostridium difficile toxin A, TNF-훼 itself did not influence
the secretion of CXCL8 [10]. The chemokine CCL20 exhib-
ited unique features as it could be induced exclusively by the
supernatant of IL-1훽 stimulated CEC that could completely
be inhibited by ATRA. This chemokine is highly specific
for its receptor CCR6, that is, expressed by intestinal CEC
and in human lymphoid tissues [30–32] and its expression is
associated with IBD [33, 34]. The importance of the CCR6-
CCL20 axis was also verified in CCR6 double negative mice
showing decreased intestinal M-cell numbers and low IgA
secretion upon rotavirus infection [35, 36]. Mk acts as a
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Figure 4: Continued.
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Figure 4: ATRApromotes the expression of CD103+ cells in in vitro differentiatedmyeloid cells.Monocytes were differentiated in the presence
of GM-CSF+IL-4 or M-CSF, respectively. The differentiated cells were treated by the supernatants of Caco2 cells preactivated by IL-1훽 or
TNF-훼 in the presence or absence of ATRA.The phenotype of the myeloid cells was characterized by measuring the cell surface expression
of 훼4훽7/CD103 and CX3CR1 on day 3 of in vitromyeloid cell differentiation by flow cytometry. Histograms show the cell surface expression
of CD103 in cells differentiated by GM-CSF+IL-4 (or M-CSF) and stimulated by the supernatants of Caco2 cells pretreated by IL-1훽 (a) or
TNF-훼 (b) and the cell surface expression of CX3CR1 in cells differentiated byM-CSF (or GM-CSF+IL-4) and stimulated by the supernatants
of Caco2 cells prestimulated by IL-1훽 (c) or TNF-훼 (d). MFI of a typical measurement out of 3–5 independent experiments is shown. Red
line depicts untreated cells, green is for cells pretreated with the supernatant of Caco2 cells activated by IL-1훽 or TNF-훼, blue is for myeloid
cells pretreated with the supernatant of Caco2 cells activated by IL-1훽 or TNF-훼 in combination with ATRA, and brown corresponds to cells
treated by the supernatant of unstimulated Caco2 cells and ATRA.
multifunctional cytokine and growth factor with bactericidal
and fungicidal activity. Upregulation of Mk expression was
also detected in the rat large intestine during DSS-induced
colitis and was shown to activate CD4+ T cells [37] leading
to enhanced mucosal restitution during the repair process of
colitis [38]. Ligation of the CXCR6 receptor by its CXCL16
ligand results in the activation of the MAP-kinase pathway
observed in patients with Crohn’s disease and was associated
with clinical benefits and rapid ulcer healing [39]. When
CEC were stimulated by IL-1훽 or TNF-훼, the secretion levels
of Mk, CXCL16, and CXCL7 remained constant while the
physiological concentrations of ATRA could decrease the
secretion of these chemokines significantly. CXCL7 was also
shown to promote neutrophil adhesion and transmigration
[40].
GM-CSF is a critical factor for DC development and
expansion in vivo; it induces DC differentiation from mono-
cytes and its absence can reduce the number ofmigratory DC
[41, 42].
Based on this information and to further characterize the
cell types involved, we generated myeloid cells with charac-
teristic phenotypic properties by differentiating them in the
presence of various growth factors (Table 2). We observed
that the myeloid cells differentiated with ATRA exerted cell
type-specific modulatory effects on their phenotype shown
by the increased expression of CD14, GM-CSF, and M-CSF
receptors, while decreasing CCR7 expression and inhibiting
memory T-cell migration to secondary lymphoid organs
Table 2: Expression of CD1a, DC-SIGN, and CD14 cell surface
molecules on monocyte-derived cells generated in the presence
of the colony stimulating factors GM-CSF+IL-4, GM-CSF, or M-
CSF. Peripheral blood-derived monocytes were differentiated in the
presence of GM-CSF+IL-4, GM-CSF, or M-CSF in RPMI + 10%
FCS for 3 days and the expression of the cell surface markers CD1a,
DC-SIGN/CD209, and CD14 was monitored by flow cytometry
using fluorescent labeled specific antibodies. The expression levels
of CD1a, DC-SIGN, and CD14 are indicated as mean fluorescence
intensity (MFI).
CD1a DC SIGN CD14
GMCSF+IL-4 200.88 32.6 75.63
GMCSF 66.31 10.5 183.29
MCSF 6.01 4.3 369.47
[43] (Supplementary Figure 2). The role of ATRA in this
process was confirmed by in vitromigration assays detecting
moderate cell migration towards the supernatant of activated
CEC containing a selected set of chemokines induced by
activated CEC. ATRA inhibited the migration of myeloid
cells differentiated in the presence of various growth factors
even when they were stimulated by the supernatant of IL-
1훽-activated Caco2 cells. These results suggest that ATRA is
a potent regulator of the tolerogenic microenvironment in
the gut acting at least partially via modulating chemokine
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Figure 5: The effect of gut epithelial cell-mediated myeloid cell stimulation on the activation and polarization of T-lymphocytes. To assess
the effects of stimulated myeloid cells on effector T-cell polarization, the supernatants of activated Caco2 cells were added to myeloid cells
differentiated by GM-CSF+IL-4, GM-CSF, or M-CSF for 3 days and the washed cells were cocultured in fresh mediumwith autologous CD4+
T-lymphocytes for another 2 days.The activation and polarization of CD4+ T-cells c-incubated with myeloid cells generated by GM-CSF+IL-
4 (a), GM-CSF (b), or M-CSF (c) was detected by the IL-17 ELISPOT assay. In the figure legends, C stands for unstimulated myeloid cells
coincubated with CD4+ T cells, EC-C for monocyte-derived cells “educated” by resting Caco2 cell supernatant followed by coincubation with
CD4+ T cells, and EC-IL-1훽, EC-TNF-훼, EC-ATRA, and EC-DMSO correspond to cultures containing monocyte-derived cells “educated”
with the supernatants of Caco2 cells pretreated with IL-1훽 or TNF-훼 in the presence or absence of ATRA, or with DMSO used as solvent
control, followed by coincubation with CD4+ T cells. ∗푃 < 0.05. Mean ± SD of the number of IL-17 secreting cells measured in 4 independent
experiments is shown.
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responses. Despite slight differences in the levels of CEC-
derived chemokine secretion, the overall effects on mod-
ulating the myeloid cell phenotype, the migratory poten-
tial, and the DC- and Mf-mediated polarization of CD4+
T-lymphocytes were comparable for the tested CEC that
involved the Caco2, HT-29, and HCT116 cell lines suggesting
a common regulatory mechanism.
Inhibited expression of the LPS-binding receptor CD14
(Supplementary Figure 2(a)) was shown to be associatedwith
increased susceptibility to gastroenteritis and UC [44] and
the expression ofGM-CSF receptorwas shown to be higher in
healthy individuals than inUCorCDpatients [45].Microbial
signals sensed by Mf in the colon are dependent on GM-
CSF and result in increased IL-1훽 secretion. In the absence of
microbes, decreased IL-1훽 secretion of mice led to low GM-
CSF levels in the gut, whileDC andMf support the generation
of Tregs by producing RA and IL-10 in the presence of TGF-훽.
The production of these regulators was drastically decreased
in the absence ofGM-CSF, as shown in퐶푠푓2−/− mice [12]. In
accordancewith these findingswe also observed the secretion
of IL-1훽 when monocyte-derived cells generated in GM-CSF
were treated with the supernatant of Caco2 cells conditioned
by ATRA (Supplementary Figure 3). In this setting ATRA
also decreased GM-CSF receptor expression (Supplementary
Figure 2(b)) which could contribute to keep the overall
concentration of IL-1훽 in the gut environment to controllable
limits. ATRA is also responsible for the homeostatic regu-
lation of CD11b+CD103+ DC [46] and under inflammatory
conditions its production is increased to keep the local
environment under check.When the chemokines were added
directly to DC to test their effects on CD103 expression, DC
could not acquire CD103 surface expression in the absence of
ATRA (Supplementary Figure 4). Based on these results, we
suggest that humanmonocyte-derived CD103+ cells, induced
by GM-CSF+IL-4 or GM-CSF together with appropriate
activation signals, that is, the supernatant of activated CEC,
are able to support the acquisition of the gut phenotype
of human DC. To confirm this finding, we also performed
experiments with blood-derived CD1c+ DC and obtained a
similar outcome (unpublished results) indicating that in the
human system both cell types can acquire the capability to
support CD103+ myeloid cell development. Differentiation of
the CX3CR1+ population in the presence of GM-CSF+IL-4
was also promoted by ATRA but it was inhibited inMf.These
results are in linewith previous results showing thatCX3CR1+
cells are inefficient in synthesizing ATRA and exhibit poor T-
cell stimulatory capacity in vitro and in vivo when injected
into intestinal lymphatics [47]. In contrast, CD103+cells are
able to migrate and can trigger adaptive immune responses
by expressing gut homing receptors on T-cells [47].
The expression of M-CSFR (Supplementary Figure 2(b))
was shown to be enhanced by IL-1훽 stimulated CEC super-
natant and the number of Th17 cells was increased when
CD4+ T cells were coincubated with Mf educated by the
supernatant of CEC preactivated by IL-1훽 in the presence of
physiological concentration of ATRA.The decreased number
of Treg cell as compared to Th17 cells has been indicated in
Crohn’s patients and the number of Tregs was influenced by
RA and IL-10 in the gut environment [10]. Bone marrow-
derived DC could be “educated” by direct contact with
murine epithelial MODE-K cells and the development of
surface expression ofCD103+ was observed, which is involved
directly in the development of Treg differentiation [48]. In
our in vitro model with human CEC (Caco2, HT-29, and
HCT116) and monocyte-derived DC, the development of
Tregs was not observed. However, we were able to demon-
strate the inhibition of Th17 cell numbers when autologous
T-cells were cocultured with “ATRA educated” DC. We also
observed the enhanced secretion of IL-10 by CD4+T-cells
after coculturing them with ATRA-conditioned DC and Mf
(Supplementary Figure 5) indicating suboptimal conditions
for Treg differentiation. It has also been shown that Th17
cells can exhibit both anti- and proinflammatory properties
depending on the cytokine signals received [49].These results
altogether indicated that the detailed characterization of the
gutmilieu under different conditions is of utmost importance
for understanding the complexity of regulation leading to the
maintenance or loss of gut homeostasis.
5. Conclusion
The proinflammatory cytokines IL-1훽 and TNF-훼, associated
with inflammatory bowel diseases, exert different effects on
gut epithelial cells monitored by the secretion of different
combinations of chemokines in CEC. The metabolite RA,
produced by both epithelial and myeloid cells, has the
potential to downmodulate some, but not all chemokine
responses to support a tolerogenic microenvironment in
the gut environment. Myeloid cells differentiated by GM-
CSF+IL-4 or GM-CSF (DC) and M-CSF (Mf) respond
differently to activated epithelial cell-mediated stimuli and to
RA.The signals provided by activated epithelial cells for DC
and Mf can be translated to T-lymphocytes, but the number
ofTh17 producing cells is modulated differentially in DC and
Mf indicating the complementary role of these myeloid cell
types in regulating adaptive effector T-cell polarization.
Conflict of Interests
The authors declare no financial or commercial conflict of
interests.
Acknowledgments
This research was supported by the European Community’s
Marie Curie project Cross Talk FP7-215553 (2007–2013) and
the European Community’s Seventh Framework Program
TORNADO-222720 (2009–2014). Tunde Fekete is acknowl-
edged for her technical advice on working with dendritic
cells.The authors also thank Erzsebet Kovacs andMarta Toth
for their outstanding technical assistance.
References
[1] M. C. Berin, M. B. Dwinell, L. Eckmann, and M. F. Kagnoff,
“Production of MDC/CCL22 by human intestinal epithelial
Mediators of Inflammation 13
cells,”The American Journal of Physiology—Gastrointestinal and
Liver Physiology, vol. 280, no. 6, pp. G1217–G1226, 2001.
[2] D. Mucida, Y. Park, G. Kim et al., “Reciprocal TH17 and
regulatory T cell differentiation mediated by retinoic acid,”
Science, vol. 317, no. 5835, pp. 256–260, 2007.
[3] M. Mark, N. B. Ghyselinck, and P. Chambon, “Function of
retinoid nuclear receptors: lessons from genetic and pharmaco-
logical dissections of the retinoic acid signaling pathway during
mouse embryogenesis,” Annual Review of Pharmacology and
Toxicology, vol. 46, pp. 451–480, 2006.
[4] I. Szatmari, A. Pap, R. Ru¨hl et al., “PPAR훾 controls CD1d
expression by turning on retinoic acid synthesis in developing
human dendritic cells,” Journal of Experimental Medicine, vol.
203, no. 10, pp. 2351–2362, 2006.
[5] M. Iwata, Y. Eshima, and H. Kagechika, “Retinoic acids exert
direct effects on T cells to suppress Tℎ1 development and
enhance Tℎ2 development via retinoic acid receptors,” Interna-
tional Immunology, vol. 15, no. 8, pp. 1017–1025, 2003.
[6] M.-A. Wurbel, M. G. McIntire, P. Dwyer, and E. Fiebiger,
“CCL25/CCR9 interactions regulate large intestinal inflamma-
tion in a murine model of acute colitis,” PLoS ONE, vol. 6, no. 1,
Article ID e16442, 2011.
[7] E. J. Villablanca, B. Cassani, U. H. von Andrian, and J. R.
Mora, “Blocking lymphocyte localization to the gastrointestinal
mucosa as a therapeutic strategy for inflammatory bowel
diseases,” Gastroenterology, vol. 140, no. 6, pp. 1776–1784, 2011.
[8] K. G.McDonald,M. R. Leach, K.W.M. Brooke et al., “Epithelial
expression of the cytosolic retinoid chaperone cellular retinol
binding protein II is essential for in vivo imprinting of local
gut dendritic cells by lumenal retinoids,” American Journal of
Pathology, vol. 180, no. 3, pp. 984–997, 2012.
[9] H.-R. Cha, S.-Y. Chang, J.-H. Chang et al., “Downregulation of
Th17 cells in the small intestine by disruption of gut flora in the
absence of retinoic acid,” Journal of Immunology, vol. 184, no. 12,
pp. 6799–6806, 2010.
[10] J. M. Kim, J. S. Kim, H. C. Jung, Y.-K. Oh, I. S. Song, and C. Y.
Kim, “Differential expression and polarized secretion of CXC
and CC chemokines by human intestinal epithelial cancer cell
lines in response to Clostridium difficile toxin A,”Microbiology
and Immunology, vol. 46, no. 5, pp. 333–342, 2002.
[11] M. Chieppa, M. Rescigno, A. Y. C. Huang, and R. N. Germain,
“Dynamic imaging of dendritic cell extension into the small
bowel lumen in response to epithelial cell TLR engagement,”
Journal of ExperimentalMedicine, vol. 203, no. 13, pp. 2841–2852,
2006.
[12] A. Mortha, A. Chudnovskiy, D. Hashimoto et al., “Microbiota-
dependent crosstalk between macrophages and ILC3 promotes
intestinal homeostasis,” Science, vol. 343, no. 6178, Article ID
1249288, 2014.
[13] F. Sallusto, C. Nicolo`, R. de Maria, S. Corinti, and R. Testi,
“Ceramide inhibits antigen uptake and presentation by den-
dritic cells,” Journal of Experimental Medicine, vol. 184, no. 6,
pp. 2411–2416, 1996.
[14] C. Varol, E. Zigmond, and S. Jung, “Securing the immune
tightrope: mononuclear phagocytes in the intestinal lamina
propria,” Nature Reviews Immunology, vol. 10, no. 6, pp. 415–
426, 2010.
[15] M. F. Neurath, “Cytokines in inflammatory bowel disease,”
Nature Reviews Immunology, vol. 14, no. 5, pp. 329–342, 2014.
[16] A. Jarry, C. Bossard, C. Bou-Hanna et al., “Mucosal IL-10 and
TGF-훽 play crucial roles in preventing LPS-driven, IFN-훾-
mediated epithelial damage in human colon explants,” Journal
of Clinical Investigation, vol. 118, no. 3, pp. 1132–1142, 2008.
[17] A. A. Te Velde, M. I. Verstege, and D. W. Hommes, “Critical
appraisal of the current practice in murine TNBS-induced
colitis,” Inflammatory Bowel Diseases, vol. 12, no. 10, pp. 995–
999, 2006.
[18] L. Shang, N.Thirunarayanan, A. Viejo-Borbolla et al., “Expres-
sion of the chemokine binding protein M3 promotes marked
changes in the accumulation of specific leukocytes subsets
within the intestine,” Gastroenterology, vol. 137, no. 3, pp.
1006.e3–1018.e3, 2009.
[19] D. Lacruz-Guzma´n, D. Torres-Moreno, F. Pedrero et al., “Influ-
ence of polymorphisms andTNF and IL1훽 serum concentration
on the infliximab response in Crohn’s disease and ulcerative
colitis,” European Journal of Clinical Pharmacology, vol. 69, no.
3, pp. 431–438, 2013.
[20] S. Hollebeeck, T. Raas, N. Piront et al., “Dimethyl sulfoxide
(DMSO) attenuates the inflammatory response in the in vitro
intestinal Caco-2 cell model,” Toxicology Letters, vol. 206, no. 3,
pp. 268–275, 2011.
[21] S. R. Yan, R. R. Joseph, J. Wang, and A. W. Stadnyk, “Differ-
ential pattern of inflammatory molecule regulation in intestinal
epithelial cells stimulatedwith IL-1,” Journal of Immunology, vol.
177, no. 8, pp. 5604–5611, 2006.
[22] D. H. Craig, J. Zhang, andM. D. Basson, “Cytoskeletal signaling
by way of 훼-actinin-1 mediates ERK1/2 activation by repetitive
deformation in human Caco2 intestinal epithelial cells,” Ameri-
can Journal of Surgery, vol. 194, no. 5, pp. 618–622, 2007.
[23] A. C. Warhurst, S. J. Hopkins, and G. Warhurst, “Interferon훾 induces differential upregulation of 훼 and 훽 chemokine
secretion in colonic epithelial cell lines,” Gut, vol. 42, no. 2, pp.
208–213, 1998.
[24] J. Torres, S. Danese, and J.-F. Colombel, “New therapeutic
avenues in ulcerative colitis: thinking out of the box,” Gut, vol.
62, no. 11, pp. 1642–1652, 2013.
[25] M. Kaur and D. Singh, “Neutrophil chemotaxis caused by
chronic obstructive pulmonary disease alveolar macrophages:
the role of CXCL8 and the receptors CXCR1/CXCR2,” Journal
of Pharmacology and ExperimentalTherapeutics, vol. 347, no. 1,
pp. 173–180, 2013.
[26] M. Cremel, W. Berlier, H. Hamzeh et al., “Characterization of
CCL20 secretion by human epithelial vaginal cells: involvement
in Langerhans cell precursor attraction,” Journal of Leukocyte
Biology, vol. 78, no. 1, pp. 158–166, 2005.
[27] P. D. Cravens and P. E. Lipsky, “Dendritic cells, chemokine
receptors and autoimmune inflammatory diseases,” Immunol-
ogy and Cell Biology, vol. 80, no. 5, pp. 497–505, 2002.
[28] M. Weber, R. Hauschild, J. Schwarz et al., “Interstitial dendritic
cell guidance by haptotactic chemokine gradients,” Science, vol.
339, no. 6117, pp. 328–332, 2013.
[29] L. R. Lopetuso, S. Chowdhry, and T. T. Pizarro, “Opposing
functions of classic and novel IL-1 familymembers in gut health
and disease,” Frontiers in Immunology, vol. 4, article 181, 2013.
[30] R. Varona, A. Zaballos, J. Gutie´rrez et al., “Molecular cloning,
functional characterization and mRNA expression analysis of
the murine chemokine receptor CCR6 and its specific ligand
MIP-3훼,” FEBS Letters, vol. 440, no. 1-2, pp. 188–194, 1998.
[31] F. Liao, R. Alderson, J. Su, S. J. Ullrich, B. L. Kreider, and J. M.
Farber, “STRL22 is a receptor for the CC chemokine MIP-3훼,”
14 Mediators of Inflammation
Biochemical andBiophysical ResearchCommunications, vol. 236,
no. 1, pp. 212–217, 1997.
[32] M. Baba, T. Imai, M. Nishimura et al., “Identification of CCR6,
the specific receptor for a novel lymphocyte- directed CC
chemokine LARC,”The Journal of Biological Chemistry, vol. 272,
no. 23, pp. 14893–14898, 1997.
[33] D. L. Rossi, A. P. Vicari, K. Franz-Bacon, T. K. McClanahan,
and A. Zlotnik, “Identification through bioinformatics of two
new macrophage proinflammatory human chemokines: MIP-
3훼 andMIP-3훽,” Journal of Immunology, vol. 158, no. 3, pp. 1033–
1036, 1997.
[34] J. C. Barrett, S. Hansoul, D. L. Nicolae et al., “Genome-wide
association defines more than 30 distinct susceptibility loci for
Crohn’s disease,” Nature Genetics, vol. 40, no. 8, pp. 955–962,
2008.
[35] D. N. Cook, D. M. Prosser, R. Forster et al., “CCR6 medi-
ates dendritic cell localization, lymphocyte homeostasis, and
immune responses in mucosal tissue,” Immunity, vol. 12, no. 5,
pp. 495–503, 2000.
[36] A. Lu¨gering, M. Floer, S. Westphal et al., “Absence of CCR6
inhibits CD+regulatory T-cell development and M-cell forma-
tion inside Peyer’s patches,”The American Journal of Pathology,
vol. 166, no. 6, pp. 1647–1654, 2005.
[37] J. Kerzerho,A. Schneider, E. Favry, F. A. Castelli, andB.Maille`re,
“The signal peptide of the tumor-shared antigen midkine hosts
CD4+ T cell epitopes,”The Journal of Biological Chemistry, vol.
288, no. 19, pp. 13370–13377, 2013.
[38] T. Yuki, S. Ishihara, M. A. K. Rumi et al., “Increased expression
of midkine in the rat colon during healing of experimental
colitis,” The American Journal of Physiology—Gastrointestinal
and Liver Physiology, vol. 291, no. 4, pp. G735–G743, 2006.
[39] J. Diegelmann, J. Seiderer, J.-H. Niess et al., “Expression and
regulation of the chemokine CXCL16 in Crohn’s disease and
models of intestinal inflammation,” Inflammatory Bowel Dis-
eases, vol. 16, no. 11, pp. 1871–1881, 2010.
[40] B. I. Schenk, F. Petersen, H.-D. Flad, and E. Brandt, “Platelet-
derived chemokines CXC chemokine ligand (CXCL)7, connec-
tive tissue-activating peptide III, andCXCL4differentially affect
and cross-regulate neutrophil adhesion and transendothelial
migration,” Journal of Immunology, vol. 169, no. 5, pp. 2602–
2610, 2002.
[41] M. Bogunovic, F. Ginhoux, J. Helft et al., “Origin of the lamina
propria dendritic cell network,” Immunity, vol. 31, no. 3, pp. 513–
525, 2009.
[42] L. van de Laar, P. J. Coffer, and A. M. Woltman, “Regulation of
dendritic cell development by GM-CSF: molecular control and
implications for immune homeostasis and therapy,” Blood, vol.
119, no. 15, pp. 3383–3393, 2012.
[43] J. D. Shields, M. E. Fleury, C. Yong, A. A. Tomei, G. J. Randolph,
and M. A. Swartz, “Autologous chemotaxis as a mechanism
of tumor cell homing to lymphatics via interstitial flow and
autocrine CCR7 signaling,” Cancer Cell, vol. 11, no. 6, pp. 526–
538, 2007.
[44] J. A. Mohamed, H. L. Dupont, J. Flores et al., “Single nucleotide
polymorphisms in the promoter of the gene encoding the
lipopolysaccharide receptor CD14 are associated with bacterial
diarrhea in US and Canadian travelers to Mexico,” Clinical
Infectious Diseases, vol. 52, no. 11, pp. 1332–1341, 2011.
[45] J. I. Goldstein, D. J. Kominsky, N. Jacobson et al., “Defective
leukocyte GM-CSF receptor (CD116) expression and function
in inflammatory bowel disease,”Gastroenterology, vol. 141, no. 1,
pp. 208–216, 2011.
[46] M. Greter, J. Helft, A. Chow et al., “GM-CSF controls nonlym-
phoid tissue dendritic cell homeostasis but is dispensable for the
differentiation of inflammatory dendritic cells,” Immunity, vol.
36, no. 6, pp. 1031–1046, 2012.
[47] O. Schulz, E. Jaensson, E. K. Persson et al., “Intestinal CD103+,
but not CX3CR1+, antigen sampling cells migrate in lymph and
serve classical dendritic cell functions,” Journal of Experimental
Medicine, vol. 206, no. 13, pp. 3101–3114, 2009.
[48] I. D. Iliev, E. Mileti, G. Matteoli, M. Chieppa, and M. Rescigno,
“Intestinal epithelial cells promote colitis-protective regula-
tory T-cell differentiation through dendritic cell conditioning,”
Mucosal Immunology, vol. 2, no. 4, pp. 340–350, 2009.
[49] R. Ramesh, L. Kozhaya, K. McKevitt et al., “Pro-inflammatory
human Th17 cells selectively express P-glycoprotein and
are refractory to glucocorticoids,” Journal of Experimental
Medicine, vol. 211, no. 1, pp. 89–104, 2014.
